ASX - By Stock
|
MSB |
Re:
2023 Next Steps
|
|
Hez
|
165 |
67K |
29 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
165
|
67K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Hez
|
3.4K |
1.2M |
29 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
6 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
6 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
4 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Hez
|
1.0K |
330K |
4 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
1.0K
|
330K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Hez
|
1.0K |
330K |
4 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
1.0K
|
330K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
Hez
|
905 |
289K |
7 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
905
|
289K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Hez
|
10K |
3.0M |
5 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Hez
|
850 |
252K |
6 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
252K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Hez
|
850 |
252K |
11 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
252K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Says Novartis Terminated Agreement With Co
|
|
Hez
|
1 |
697 |
10 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
1
|
697
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Nature publication
|
|
Hez
|
32 |
12K |
5 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
32
|
12K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Nature publication
|
|
Hez
|
32 |
12K |
13 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
32
|
12K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
New Covid 19 treatment
|
|
Hez
|
444 |
92K |
0 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
444
|
92K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
0 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Give Tommy a Headline!
|
|
Hez
|
77 |
17K |
0 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
77
|
17K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Great Company, Great Future!
|
|
Hez
|
81 |
20K |
21 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
81
|
20K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2021 Full Year Financial Results Webcast
|
|
Hez
|
195 |
64K |
1 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
195
|
64K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2021 Full Year Financial Results Webcast
|
|
Hez
|
195 |
64K |
1 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
195
|
64K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Hez
|
4.7K |
1.1M |
4 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Hez
|
4.7K |
1.1M |
7 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Hez
|
10K |
3.0M |
8 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
1 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
Hez
|
1.5K |
505K |
8 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
1.5K
|
505K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
5 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Australian Newspaper MSB trial failure
|
|
Hez
|
255 |
70K |
0 |
17/07/21 |
17/07/21 |
ASX - By Stock
|
255
|
70K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Respiratory Outcomes Presented
|
|
Hez
|
163 |
61K |
9 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
163
|
61K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
Hez
|
1.6K |
464K |
3 |
11/07/21 |
11/07/21 |
ASX - By Stock
|
1.6K
|
464K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
Hez
|
1.6K |
464K |
8 |
11/07/21 |
11/07/21 |
ASX - By Stock
|
1.6K
|
464K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
Hez
|
260 |
81K |
1 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
260
|
81K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Hez
|
10K |
3.0M |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
2 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
1 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
4 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
6 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Hez
|
10K |
3.0M |
1 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
Hez
|
429 |
130K |
4 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
429
|
130K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cup and Handle Chart Pattern
|
|
Hez
|
249 |
55K |
17 |
13/03/21 |
13/03/21 |
ASX - By Stock
|
249
|
55K
|
17
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Hez
|
10K |
3.0M |
1 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
4 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Hez
|
10K |
3.0M |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Partnership Announcements
|
|
Hez
|
90 |
32K |
2 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
90
|
32K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Monash Uni Research - Diabetes Cure!
|
|
Hez
|
10 |
3.0K |
2 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
10
|
3.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Hez
|
17K |
6.7M |
7 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Hez
|
1.1K |
314K |
0 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Hez
|
1.1K |
314K |
0 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Hez
|
1.1K |
314K |
2 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Hez
|
1.1K |
314K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
314K
|
0
|
|